News about Global Pharma

argenx Secures FDA Approval for VYVGART Hytrulo Co-Formulated with ENHANZE

Halozyme Therapeutics has announced that argenx has received US Food and Drug Administration (FDA) approval for VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) co-formulated with ENHANZE, Halozyme's proprietary recombinant human hyaluronidase enzyme, rHuPH20, for the treatment of adults with chronic inflammatory demyelinating polyneuropathy.

Global Pharma | 24/06/2024 | By Aishwarya |  750

Abzena and Argonaut to Offer End-to-End Drug Development Support for Biopharma Companies

Abzena has inked a strategic partnership with Argonaut Manufacturing Services, Inc. to provide a fully integrated drug substance and drug product manufacturing solution for biopharmaceutical organizations.

Global Pharma | 21/06/2024 | By Aishwarya |  800

Johnson & Johnson Submits Application to US FDA Seeking Approval of TREMFYA

Johnson & Johnson has submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) seeking approval of TREMFYA (guselkumab) for the treatment of adults with moderately to severely active Crohn's disease.

Global Pharma | 21/06/2024 | By Aishwarya |  567

Regel Therapeutics Names Stephen J. Farr as New CEO

Regel Therapeutics’ Board of Directors has named Stephen J. Farr, PhD, as the new Chief Executive Officer (CEO).

Global Pharma | 21/06/2024 | By Aishwarya |  440

iOnctura Secures EUR 80 Million in Series B Financing Round

iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, has closed a EUR 80 million Series B financing.

Global Pharma | 21/06/2024 | By Aishwarya |  789

Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support

Under the terms of the agreement, TrueNorth Medical Physics will offer services that are complementary and supplementary to those supplied by Accuray, acting as an extension of the hospital team – on-site, remote or hybrid – to help ensure they have the staffing needed to achieve patient treatment goals.

Global Pharma | 20/06/2024 | By Manvi |  548

Aranscia and Signature RX Announce Personalized Medication Management Program for GLP-1s

Aranscia announced a partnership to develop novel biomarkers and a personalized medication management solution for the effective use of GLP-1 medications.

Global Pharma | 20/06/2024 | By Manvi |  432

Corealis Launches New Facilities in Laval Science Park

Corealis Pharma Inc. has expanded its facilities nestled in the heart of Laval's Biotech City, in the presence of the esteemed Christopher Skeete, Minister for the Economy, and Christine Poirier, Laval City Councillor.

Global Pharma | 20/06/2024 | By Aishwarya |  712

Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo

Zynext Ventures USA LLC (Zynext Ventures), the Venture Capital (VC) arm of Zydus Lifesciences announced its investment in Promaxo Inc. (Promaxo).

Global Pharma | 19/06/2024 | By Manvi |  1487

ALPLA Group Announces Acquisition of Heinlein Plastik-Technik

The ALPLA Group has been expanding its pharma division ALPLApharma with the acquisition of Heinlein Plastik-Technik GmbH.

Global Pharma | 19/06/2024 | By Manvi |  1147